Sanderling Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 7
Professionals
  • Investments
  • 157
  • Portfolio
  • 18
  • Exits
  • 63
Exits

Sanderling Ventures General Information

Description

Sanderling Ventures is a venture capital firm that was founded in 1979 and is based in San Mateo, California. The firm prefers to invest in the biotechnology, life sciences, therapeutics and pharmaceuticals, drug delivery, medical devices and instrumentation, diagnostics, medical informatics, healthcare information technology and health care services sectors.

Contact Information

Year Founded
1979
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Limited Partner
Primary Office
  • 400 South El Camino Real
  • Suite 1200
  • San Mateo, CA 94402
  • United States
+1 (650) 000-0000

Sanderling Ventures Investments (157)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
ViaCyte 26-May-2020 Later Stage VC 0000 Drug Discovery Clinical Trials - General 0000 000000000
00000000000 22-May-2020 00000 00000 000.00 Drug Discovery Clinical Trials - General 000000 000000 00.0
000000000 07-Aug-2019 00000 00000 0000 Drug Discovery Clinical Trials - General 0000000 00000
00000 000000000000 10-May-2019 0000 00000 Biotechnology Product Development 000000 000000 00.0
00000000000 15-Dec-2017 00000 00000 0000 Therapeutic Devices Generating Revenue 0000000 00000
0000000000 000000 23-Aug-2017 0000 00000 000 Biotechnology Startup
0000000000 27-Jul-2017 00000 00000 0000 Biotechnology Generating Revenue 00000 0000000000 00.0
000000 00000000 17-Jul-2017 00000 00000 000.00 Monitoring Equipment Generating Revenue/Not Profitable 000000 000000 00.0
PreciThera 10-May-2017 Seed Round Biotechnology Generating Revenue 000000 00000000000 00.0
Glycomine 16-Nov-2016 Early Stage VC 0000 Drug Discovery Clinical Trials - General 00000 0000000000 00.0
You’re viewing 10 of 157 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sanderling Ventures Exits (63)

Company Name Exit Date Exit Type Exit Size
Lineagen 24-Aug-2020 Merger/Acquisition 0000
000000 00000000000 01-Nov-2017 000 00 00000000
00000 0000000000 01-Aug-2017 000000000000000000 000
00000000 01-Jun-2017 0000000000: 000000
00000 0000000 23-Mar-2017 000000000000000000
000000 00000000 08-Dec-2016 000000000000000000
00000000 01-Dec-2016 000 00 00000000
000000 00000000 07-Oct-2016 0000000000: 000000
Skyepharma 10-Jun-2016 Merger/Acquisition 00000
Infraredx 31-Oct-2015 Merger/Acquisition 0000
You’re viewing 10 of 63 exits. Get the full list »

Sanderling Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Sanderling Ventures‘s full profile, request access.

Request a free trial

Sanderling Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Sanderling Ventures Team (22)

Name Title Deals Funds Boards Office
Timothy Wollaeger Managing Director Emeritus 00 0 0 San Mateo, CA
Norman Marcus MD Venture Partner San Diego, CA
Benjamin McGraw III Venture Partner 0 San Mateo, CA
Paulette Taylor JD General Counsel & Principal 0 0 San Mateo, CA
Robert Mcneil Ph.D Founder & Managing Director 00 0 0 San Mateo, CA
You’re viewing 5 of 22 team members. Get the full list »

Sanderling Ventures Co-Investors (24)

Name With Exits Lead Partner Series Industry
Bain Capital 1 0 Series chart Industry bar
GeneChem 0 0 Series chart Industry bar
New Enterprise Associates 0 0 Series chart Industry bar
Novo Holdings 0 0 Series chart Industry bar
Versant Venture 0 0 Series chart Industry bar
You’re viewing 5 of 24 co-investors. Get the full list »